GlassScriptPhysician profile
Lawrence A Greenberg
NPI 1568459196
$1,124.81
in general payments reported to CMS, 2019-2025
22 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.08 · 2020: $134 · 2021: $320 · 2022: $87.49 · 2023: $172 · 2024: $209 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454 · Consulting Fee: $60.00 · Education: $16.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.88 |
| Consulting Fee | $60.00 |
| Education | $16.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Amgen INC. | $198.49 | 2019-2024 | Tavneos, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $150.02 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $79.98 | 2021-2023 | |
| Axsome Therapeutics, INC. | $60.98 | 2024-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.15 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $60.00 | 2023 | Benlysta |
| Horizon Therapeutics Plc | $59.34 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $24.26 | 2023 | |
| Boston Scientific Corporation | $21.23 | 2024 | Varithena Administration Pack |
| Pfizer INC. | $20.83 | 2023 | |
| Aurinia Pharma U.S., INC. | $19.69 | 2022 | |
| Novo Nordisk INC | $19.53 | 2025 | Wegovy |
| Sumitomo Pharma America, INC. | $19.04 | 2025 | Gemtesa |
| Lundbeck LLC | $18.97 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.45 | 2024 | Rexulti |
| Exact Sciences Corporation | $17.50 | 2025 | Cologuard Collection Kit |
| Aimmune Therapeutics, INC. | $16.95 | 2024 | |
| Travere Therapeutics, INC. | $16.89 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.27 | 2021 | |
| Mallinckrodt Hospital Products INC. | $15.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.24 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Greenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.